I agree with both of you. He should keep whatever core shares he's comfortable with and if he wants to trade long around a core do that.
I have to say that based on fanofstan pointing out his following of Rockwell's previous takeouts and seeing them really start to turn the corner here and right the ship, the CEO is honest and is not blowing smoke up anyone's behind. Hopefully they can continue building on their success.
He finally seems to have the C-Suite set up correctly and their time is coming.
That's the thing johhny. Given the perma 24/7 posting bear on the board who has no position, multiple people showing up on this makes long timers here more skeptical of the posters.
Good luck with your future investments.
Thanks johnny, I can understand posting given your experience with someone you would not trust given your past experience with them selling you a bill of goods.
I can appreciate that johnny. Did you just happen to stumble into the PR? Did you feel she misled people?
Was that 80% margin quoted from Management or is it in there 10k or 10q?
It seems like a large number. What is the actual price point per packet?
I'm not brow beating you but I'm just curious what made you post on this board?
Do you track RMTI?
Do you purposely track the former NBS CEO?
You have to understand this is a battleground stock.
Admittedly Management has played it close to the vest and has not delivered meaningful sales in their two most recently approved drugs.
That said the stock is heavily shorted and there is a bear on the board who has no stake supposedly and posts more than anybody with supposedly no interest in the stock the last I heard. i have him on ignore.
You can understand why people might be skeptical about someone new to this forum with no skin in the game.
You are pretty much correct especially for someone who has always been bullish here like beermenow5.
Wouldn't he be kicking himself if after all this time the stock got away from him?
I have a small position mostly because I'm pretty much fully invested.
I'm holding onto some and occasionally will trade a 1000 share lot.
The algos will hose you out of a few cents but that's to be expected as the crooks run the show.
Certainly there is more negative priced in here than positive but be sure if the CMS answer comes back negative this will drop to new lows I would think especially when HFTs and algos can be used to drive it into the ground without big demand.
That said I would think the risk/reward here is decent.
Please do the math for us because I know it's a new drug or was a new drug that will soon be selling but the numbers you provide as a stand alone vs a $367M market cap don't mean much.
It you add the trajectory of growth you are thinking of it could help. Is it any different than the current estimates we see on this site?
Actually I just read another piece that said the polls close at 5PM ET. If true, we may or may not have an idea of where it stands before EOD today.
Obviously if it's very close we still won't know until later.
That's exactly what it looks like and on any weakness tomorrow the high 9s could be in play and of course if the Brexit happens that will be an excuse to knock things down.
You probably want to hold onto some in case they don't flush but whatever you're comfortable with.
RSI on the daily at the close at 29.1 and Money flow at 4.6. Not pretty. So oversold but stocks can stay oversold for a while.
I follow another small bio acting just as poorly as this so I'm not sure if this is foreshadowing any bad news or not. They can beat this stocks into the ground and it seems like Brexit is totally not priced in while it's really a coin toss at this point.
What was max pain Friday? I thought it might have been $9 but it could have been $8. If $9, it didn't work for 54it.
I just looked at July and August and they both show $8. With a stock like this this far away I don't think it's that reliable of an indicator.
The daily RSI cracked 30 earlier and the daily money flow was down to 19. Not a lot volatility really. $7.30 held so far as the recent low but it looks like it wants to go lower. We'll see.
Actually in reading this gain it seems like the impact is positioned to be small even if cuts go through for the future.
Overall I do think the sentiment is still a bit negative but the reality is biotech is a large growth engine in a low growth economy BUT the less risks will be taken if the reward is not seen by those that would invest within biotech with their smarts/science/effort and investors that would actually put their money behind it if they don't think they will ultimately get paid for success.